Order Article Reprints

Long Z, Lu Y, Li M, Fu Z, Akbar Y, Li J, Chen G, Zhang H-M, Wang Q, Xiang L, et al. Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas. Cancers. 2023; 15(3):700. https://doi.org/10.3390/cancers15030700

Long, Zuoyao, Yajie Lu, Minghui Li, Zhanli Fu, Yunus Akbar, Jing Li, Guojing Chen, Hong-Mei Zhang, Qi Wang, Liangbi Xiang, and et al. 2023. "Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas" Cancers 15, no. 3: 700. https://doi.org/10.3390/cancers15030700

Long, Z., Lu, Y., Li, M., Fu, Z., Akbar, Y., Li, J., Chen, G., Zhang, H.-M., Wang, Q., Xiang, L., & Wang, Z. (2023). Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas. Cancers, 15(3), 700. https://doi.org/10.3390/cancers15030700